Look Who it Was Random video

Organigram Holdings Inc (CVE:OGI) CEO introduces Cutting-Edge Technology

1,739 views · Published 13 July 2018 · 5:35 · Indexed 23 September 2026

Channel: Midas Letter · 2018 · News & Politics

Watch on YouTube

Organigram Holdings Inc (CVE:OGI) (OTCMKTS:OGRMF) (FRA:0OG) CEO Greg Engel discusses their strategic investment in Hyasynth Biologicals, Inc. Hyasynth have developed patent-pending technologies to engineer the precursor of cannabinoids from yeast which are ultimately converted into CBG, CBD, and THC compounds, identical to those found in the cannabis plant. Organigram believes the technology has massive potential to catalyze the marketplace by allowing the production of identical phytocannabinoids on a large scale at a low cost. The applications could be huge as companies move into producing more derivative-based cannabis products such as edibles and beverages.

************************

Check out our website: 
https://midasletter.com

************************

SUBSCRIBE to our YouTube: 
http://bit.ly/MidasLetterYoutube 

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter 

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter: 
http://bit.ly/MidasLetterTwitter

Like Us on Instagram: 
http://bit.ly/MidasLetterInsta 

Like Us on Facebook: 
http://bit.ly/MidasLetterFacebook

************************

More from this channel